Insider Trading & Ownership - Farzan Nima

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Farzan Nima

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-30
Option Award
2024-06-03
4:15 pm
N/A
2034-05-29
Keros Therapeutics Inc.KROSFarzan Nima
Director
10,000$010,000
(Direct)
View
2024-04-03
Disposition
2024-04-05
4:55 pm
N/A
2030-03-23
Kinnate Biopharma Inc.KNTEFarzan Nima
CHIEF EXECUTIVE OFFICER
3,146,241$00
(Direct)
View
2023-06-06
Option Award
2023-06-08
4:38 pm
N/A
2033-06-05
Keros Therapeutics Inc.KROSFarzan Nima
Director
10,000$010,000
(Direct)
View
2023-02-10
Option Award(A)
2023-02-15
11:01 am
N/A
2033-02-10
Kinnate Biopharma Inc.KNTEFarzan Nima
Chief Executive Officer
750,000$0750,000
(Direct)
View
2023-02-10
Option Award
2023-02-14
5:00 pm
N/A
2033-02-10
Kinnate Biopharma Inc.KNTEFarzan Nima
Chief Executive Officer
750,000$0215,000
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:24 pm
N/A
2032-05-31
Keros Therapeutics Inc.KROSFarzan Nima
Director
8,293$08,293
(Direct)
View
2022-02-11
Option Award
2022-02-15
4:00 pm
N/A
2032-02-11
Kinnate Biopharma Inc.KNTEFarzan Nima
Chief Executive Officer
400,000$0400,000
(Direct)
View
2021-06-01
Option Award
2021-06-03
5:29 pm
N/A
2031-05-31
Keros Therapeutics Inc.KROSFarzan Nima
Director
8,293$08,293
(Direct)
View
2021-02-12
Option Award
2021-02-16
5:54 pm
N/A
2031-02-12
Kinnate Biopharma Inc.KNTEFarzan Nima
Chief Executive Officer
275,000$0275,000
(Direct)
View

Ownership
2020-12-02
9:14 pm
2020-03-23
2030-03-23
Kinnate Biopharma Inc.KNTEFarzan Nima
President and CEO
0$01,719,055
(Direct)
View
2020-05-29
Option Award
2020-05-29
5:19 pm
N/A
2030-05-29
Keros Therapeutics Inc.KROSFarzan Nima
Director
8,500$08,500
(Direct)
View
(A) Indicate amendment filing.